Idolor Osahon N, Guraya Armaan, Muojieje Chukwudi C, Kannayiram Sandhya Shri, Nair Karun M, Odion Jesse, Sanwo Eseosa, Aihie Osaigbokan P
Internal Medicine, College of Medicine, University of Benin, Benin, NGA.
College of Osteopathic Medicine, Midwestern University Chicago, Chicago, USA.
Cureus. 2021 Jan 5;13(1):e12515. doi: 10.7759/cureus.12515.
Background This study aims to compare outcomes of hospitalizations of granulomatosis with polyangiitis (GPA) with and without renal involvement. The primary outcome was inpatient mortality, whereas secondary outcomes were hospital length of stay (LOS) and total hospital charge. Methods Data were abstracted from the National Inpatient Sample (NIS) 2016 and 2017 databases. The NIS was searched for GPA hospitalizations with and without renal involvement as the principal or secondary diagnosis using International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10) codes. GPA hospitalizations for adult patients from the above groups were identified. Multivariate logistic and linear regression analyses were used to adjust for possible confounders for the primary and secondary outcomes, respectively. Results There were more than 71 million discharges included in the combined 2016 and 2017 NIS database, of which 23,670 were for adult patients who had either a principal or secondary ICD-10 code for GPA, and 8,265 (34.92%) of these GPA hospitalizations had renal involvement. Hospitalizations for GPA with renal involvement had similar inpatient mortality (3.8% vs. 3.7%; adjusted OR: 1.14; 95% CI: 0.84-1.56; p=0.406) compared to those without renal involvement. GPA with renal involvement hospitalizations had an increase in adjusted mean LOS of 1.36 days (95% CI: 0.82-1.91; p=0.0001) compared to those without renal involvement. GPA with renal involvement hospitalizations had an increase in adjusted total hospital charges of $18,723 (95% CI: 9,595-27,852; p=0.0001) compared to those without renal involvement. Conclusions GPA with renal involvement hospitalizations had similar inpatient mortality compared to those without renal involvement. However, LOS and total hospital charges were greater in those with renal involvement.
背景 本研究旨在比较肉芽肿性多血管炎(GPA)合并和不合并肾脏受累的住院结局。主要结局为住院死亡率,次要结局为住院时间(LOS)和总住院费用。方法 数据取自2016年和2017年的全国住院患者样本(NIS)数据库。使用国际疾病分类第十版临床修订本(ICD-10)编码在NIS中搜索以GPA合并或不合并肾脏受累作为主要或次要诊断的住院病例。确定上述组中成年患者的GPA住院病例。分别使用多因素逻辑回归和线性回归分析对主要和次要结局的可能混杂因素进行校正。结果 2016年和2017年的NIS联合数据库中包含超过7100万例出院病例,其中23670例为成年患者,其主要或次要ICD-10编码为GPA,这些GPA住院病例中有8265例(34.92%)合并肾脏受累。与不合并肾脏受累的患者相比,合并肾脏受累的GPA住院患者的住院死亡率相似(3.8%对3.7%;校正后的OR:1.14;95%CI:0.84-1.56;p=0.406)。与不合并肾脏受累的患者相比,合并肾脏受累的GPA住院患者的校正后平均住院时间增加了1.36天(95%CI:0.82-1.91;p=0.0001)。与不合并肾脏受累的患者相比,合并肾脏受累的GPA住院患者的校正后总住院费用增加了18723美元(95%CI:9595-27852;p=0.0001)。结论 与不合并肾脏受累的患者相比,合并肾脏受累的GPA住院患者的住院死亡率相似。然而,合并肾脏受累的患者的住院时间和总住院费用更高。